Clincosm LogoSign in Get a demo

Colorectal Carcinoma

Showing 26 - 50 of 166
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Colorectal Carcinoma Trial in Atlanta (Internet-Based Intervention, Interview, Survey Administration)

Not yet recruiting
  • Colorectal Carcinoma
  • Internet-Based Intervention
  • +3 more
  • Atlanta, Georgia
    Emory University/Winship Cancer Institute
Dec 21, 2022

Colorectal Carcinoma Trial in Seattle, Sequim (Educational Intervention, Fecal Immunochemical Test, Questionnaire

Terminated
  • Colorectal Carcinoma
  • Educational Intervention
  • +2 more
  • Seattle, Washington
  • +1 more
Dec 13, 2022

Advanced Solid Tumors, Glioblastoma, Soft Tissue Sarcoma (Excluding GIST) Trial in Boston, Madrid, Sevilla (Lurbinectedin,

Recruiting
  • Advanced Solid Tumors
  • +11 more
  • Boston, Massachusetts
  • +4 more
Dec 12, 2022

Melanoma, Breast Carcinoma, Hepatocellular Carcinoma Trial in United States (XmAb20717)

Completed
  • Melanoma
  • +27 more
  • XmAb20717
  • Los Angeles, California
  • +16 more
Nov 29, 2022

Breast Carcinoma, Colorectal Carcinoma, Lung Carcinoma Trial in Seattle (Survivorship Care Plan, Educational Intervention,

Enrolling by invitation
  • Breast Carcinoma
  • +4 more
  • Survivorship Care Plan
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Nov 22, 2022

Rectal Adenocarcinoma, Rectum Tumor, Rectum Carcinoma Trial in Helsinki, Tampere, Turku (Oral Antibiotics, Placebo, Mechanical

Active, not recruiting
  • Rectal Adenocarcinoma
  • +7 more
  • Oral Antibiotics
  • +2 more
  • Helsinki, Finland
  • +2 more
Nov 16, 2022

Melanoma, Prostate Cancer, Ovarian Cancer Trial in United States (Pegilodecakin, Paclitaxel or Docetaxel and Carboplatin or

Active, not recruiting
  • Melanoma
  • +8 more
  • Los Angeles, California
  • +9 more
Nov 15, 2022

Colorectal Carcinoma Trial (mFOLFOX6, FOLFIRI, pembrolizumab)

Active, not recruiting
Has Results
  • Colorectal Carcinoma
  • (no location specified)
Oct 28, 2022

Non-small-cell Lung Cancer, Squamous Cell Carcinoma of the Head and Neck, Renal Cell Carcinoma Trial in United States

Active, not recruiting
  • Non-small-cell Lung Cancer
  • +5 more
  • PF-07209960
  • Duarte, California
  • +11 more
Oct 10, 2022

Uterine Cervical Cancer, Uterine Cervix Cancer, Uterine Cervical Tumor Trial in Randers (Screening status)

Active, not recruiting
  • Uterine Cervical Cancer
  • +7 more
  • Screening status
  • Randers, Denmark
    Anne Dorte Lerche Helgestad
Sep 21, 2022

Reproductive and Sexual Health in People With Early Onset

Recruiting
  • Colorectal Cancer
  • +2 more
  • Hormone biomarker analysis
  • QoL Questionnaires
  • Hartford, Connecticut
  • +7 more
Sep 8, 2022

Diseases of Liver, Colon Carcinoma, Colorectal Carcinoma Trial in Houston (Computed Tomography Scan - 50% Dose Reduction,

Recruiting
  • Diseases of Liver
  • +3 more
  • Computed Tomography Scan - 50% Dose Reduction
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Aug 22, 2022

Ovarian Cancer, Ovarian Tumors, Ovarian Carcinoma Trial in United States (ELU001)

Recruiting
  • Ovarian Cancer
  • +68 more
  • Phoenix, Arizona
  • +8 more
Aug 18, 2022

Advanced Malignant Solid Tumor, Bladder Carcinoma, Breast Carcinoma Trial in Guam, Puerto Rico, United States (drug, procedure,

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +49 more
  • Birmingham, Alabama
  • +1429 more
Aug 17, 2022

Hepatocellular Carcinoma, Hepatocellular Cancer, Colorectal Cancer Trial in Singapore (Neoantigen Dendritic Cell Vaccine,

Recruiting
  • Hepatocellular Carcinoma
  • +4 more
  • Singapore, Singapore
    National Cancer Center Singapore
Aug 17, 2022

Breast Carcinoma, Cervical Carcinoma, Colorectal Carcinoma Trial in Seattle (Training, Cancer Screening intervention, Survey

Completed
  • Breast Carcinoma
  • +3 more
  • Training
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jul 22, 2022

Colorectal Carcinoma Trial in Seattle (Media Intervention, Best Practice, Questionnaire Administration)

Not yet recruiting
  • Colorectal Carcinoma
  • Media Intervention
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jul 11, 2022

Breast Carcinoma, Colorectal Carcinoma Trial in San Francisco (Best Practice, Informational Intervention, Questionnaire

Completed
  • Breast Carcinoma
  • Colorectal Carcinoma
  • Best Practice
  • +3 more
  • San Francisco, California
    University of California San Francisco
Jul 7, 2022

Psychological, Psychophysical and Epigenetic Determinants of

Recruiting
  • Appendix Carcinoma
  • +5 more
  • Biospecimen Collection
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 28, 2022

Pancreatic Cancer, Breast Cancer, Gastric Cancer Trial in United States (NGM831, NGM831 plus pembrolizumab)

Recruiting
  • Pancreatic Cancer
  • +15 more
  • Gilbert, Arizona
  • +4 more
Jun 21, 2022

Colorectal Cancer, Colorectal Tumors, Colorectal Carcinoma Trial in Worldwide (Nivolumab, Trametinib, Ipilimumab)

Recruiting
  • Colorectal Cancer
  • +3 more
  • Nivolumab
  • +3 more
  • Birmingham, Alabama
  • +101 more
Jun 13, 2022

Colon Cancer, Colorectal Cancer, Colorectal Carcinoma Trial in Tampa (Pembrolizumab, Ibrutinib)

Completed
Has Results
  • Colon Cancer
  • +3 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jun 1, 2022

Colorectal Carcinoma Trial in Austria (endurance exercise, control)

Recruiting
  • Colorectal Carcinoma
  • endurance exercise
  • control
  • Graz, Styria, Austria
  • +8 more
May 24, 2022

Colorectal Carcinoma, Lung Adenocarcinoma, Malignant Solid Tumor Trial in Buffalo (Binimetinib, Palbociclib, Therapeutic

Recruiting
  • Colorectal Carcinoma
  • +3 more
  • Buffalo, New York
    Roswell Park Cancer Institute
May 11, 2022

Colorectal Carcinoma Trial in Columbus (Educational Intervention, Survey Administration)

Active, not recruiting
  • Colorectal Carcinoma
  • Educational Intervention
  • Survey Administration
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
May 9, 2022